Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Response to Liquid CAIV-T Influenza Vaccine in Healthy Adults
NCT00192192Phase 3Completed
- Sponsor
- MedImmune
- Start
- Nov 2000
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of live attenuated influenza vaccine in influenza, sponsored by MedImmune. Started Nov 2000; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00192192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00192192.